SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-15-000242
Filing Date
2015-02-17
Accepted
2015-02-17 16:09:30
Documents
1
Group Members
JOSEPH EDELMANPERCEPTIVE ADVISORS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sarepta_13ga1.htm SC 13G/A 85387
  Complete submission text file 0001019056-15-000242.txt   87233
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 15622385
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A